FCG Investment Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.22M Buy
8,748
+653
+8% +$152K 0.77% 35
2026
Q1
$1.98M Buy
+8,095
New +$1.89M 0.87% 29
2025
Q3
$1.81M Sell
9,780
-2,755
-22% -$472K 0.85% 32
2025
Q2
$1.91M Sell
12,535
-3,508
-22% -$539K 1% 25
2025
Q1
$2.66M Buy
16,043
+5,777
+56% +$904K 1.67% 15
2024
Q4
$1.48M Sell
10,266
-4,143
-29% -$642K 0.9% 33
2024
Q3
$2.34M Buy
14,409
+9,894
+219% +$1.58M 1.53% 18
2024
Q2
$660K Sell
4,515
-1,203
-21% -$179K 0.5% 59
2024
Q1
$905K Buy
5,718
+699
+14% +$111K 0.72% 49
2023
Q4
$787K Buy
+5,019
New +$770K 0.77% 35

Other funds holding JNJ

FCG Investment Company's JNJ Position: Q2 2026 in Review

FCG Investment Company increased its Johnson & Johnson (JNJ) stake by 8.1% in Q2 2026, buying an estimated $152K and bringing the position to 8,748 shares worth $2.22M. The position accounts for 0.77% of the portfolio, ranked #35.

FCG Investment Company first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.66M in Q1 2025. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • FCG Investment Company held 8,748 shares of Johnson & Johnson worth $2.22M as of Q2 2026.
  • FCG Investment Company bought 653 Johnson & Johnson shares in Q2 2026, an estimated $152K.
  • Johnson & Johnson made up 0.77% of FCG Investment Company's portfolio in Q2 2026, its #35 holding.
  • FCG Investment Company first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • FCG Investment Company's Johnson & Johnson position peaked at $2.66M in Q1 2025.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on FCG Investment Company's 13F filing for Q2 2026, filed 13 Jul 2026.